Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. pharmaceutical care solutions
WARNING LETTER
•pharmaceutical care solutions •January 24, 2020

pharmaceutical care solutions – FDA Warning Letter, Jan 24, 2020

Record Details

On August 2, 2021, the FDA issued a Warning Letter to Pharmaceutical Care Solutions dba Pharmacy Solutions following an inspection from January 15-24, 2020. The inspection revealed the firm produced drug products that failed to meet the conditions for exemption under Section 503A of the Federal Food, Drug, and Cosmetic Act (FDCA), rendering them unapproved new drugs and misbranded.

Violations include compounding drug products using ammonium tetrathiomolybdate, which is not on the 503A bulks list, is not a component of an FDA-approved drug, and lacks a USP/NF monograph. Additionally, the firm used bulk drug substances manufactured by an unregistered establishment ((b)(4)) under Section 510 of the FDCA. These actions mean the compounded drugs are not exempt from FDA approval (Section 505), adequate labeling requirements (Section 502(f)(1)), and current good manufacturing practice (CGMP) regulations (Section 501(a)(2)(B)).

The firm's February 14, 2020, response was deemed deficient as it did not agree to cease compounding with ammonium tetrathiomolybdate and failed to address the use of substances from unregistered establishments. The FDA noted that ammonium tetrathiomolybdate's nomination for the 503A bulks list was withdrawn, and tranilast

Company
pharmaceutical care solutions
Inspection date
January 24, 2020
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations III
Person
  • Art O. Czabaniuk (Program Division Director)
View Company Profile

ID · 9cb35aed-9451-40ed-891b-6865552027df

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 353a21 U.S.C. 352(f)(1)21.U.S.C. 355(a)21 U.S.C. 36021 U.S.C. 331(d)21 U.S.C. 321(p)FD&C Act 501(a)(2)(B)FD&C Act 502(f)(1)FD&C Act 505

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore pharmaceutical care solutions
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.